Best investigated DCB
In the last 12 years, B. Braun’s SeQuent® Please product family has demonstrated its functionality and efficacy for coronary lesion therapy underlined with a significant clinical evidence portfolio of more than 110 published studies.
The SeQuent® Please NEO is a drug coated balloon catheter for treating stenosis of coronary arteries with PTCA, while leaving nothing behind. The catheter has a matrix coating of paclitaxel and Iopromide (PACCOCATH®-Technology), which helps to keep coronary arteries open by inhibiting smooth muscle cell proliferation and migration.
- Importance of Lesion Preparation for improved clinical outcomes
- This implant-free treatment requires only one month of DAPT
- The proven coating technology in more than 110 studies
SeQuent® Please NEO Clinically proven drug coated balloon catheter
|pdf (1.9 MB)||open|
SeQuent® Please NEO – Go Implant-Free! Safe and effective alternative to DES in de novo lesions
|pdf (27.8 KB)||open|
Cardiology Catalog Your partner for coronary angioplasty
|pdf (1.8 MB)||open|